Should screening for DPD deficiency be mandatory before 5-FU exposure?

W Schwabe, D Behnke, P Häusler, A B Van Kuilenburg, K Höffken, A H Van Gennip, M Raida, Prevalence of a Common Point Mutation in the Dihydropyrimidine Dehydrogenase (DPD) Gene within the 5′-Splice Donor Site of Intron 14 in Patients with Severe 5-Fluorouracil (5-FU)- related Toxicity Compared with Controls Clinical Cancer Research. ,vol. 7, pp. 2832- 2839 ,(2001)

M C Etienne, J L Lagrange, O Dassonville, R Fleming, A Thyss, N Renée, M Schneider, F Demard, G Milano, Population study of dihydropyrimidine dehydrogenase in cancer patients. Journal of Clinical Oncology. ,vol. 12, pp. 2248- 2253 ,(1994) , 10.1200/JCO.1994.12.11.2248

André B P van Kuilenburg, Lida Zoetekouw, Koichi Matsuda, Frank Baas, Albert H van Gennip, Rutger Meinsma, Bernard A Zonnenberg, Nanaya Tamaki, Dihydropyrimidinase Deficiency and Severe 5-Fluorouracil Toxicity Clinical Cancer Research. ,vol. 9, pp. 4363- 4367 ,(2003)

Barry E. Harris, John T. Carpenter, Robert B. Diasio, Severe 5-fluorouracil toxicity secondary to dihydropyrimidine dehydrogenase deficiency. A potentially more common pharmacogenetic syndrome. Cancer. ,vol. 68, pp. 499- 501 ,(1991) , 10.1002/1097-0142(19910801)68:3<499::AID-CNCR2820680309>3.0.CO;2-F

G.A. Milano, M.H. Gaspard, A. Thyss, N. Renée, M. Schneider, F. Demard, R.A. Fleming, P.J. Bargnoux, R. Plagne, Dihydropyrimidine dehydrogenase activity in cancer patients European Journal of Cancer. ,vol. 29, pp. 740- 744 ,(1993) , 10.1016/S0959-8049(05)80358-2

A. Lazar, U. A. Mau-Holzmann, H. Kolb, H. E. Reichenmiller, O. Riess, OE. Schömig, Multiple Organ Failure due to 5-Fluorouracil Chemotherapy in a Patient with a Rare Dihydropyrimidine Dehydrogenase Gene Variant Onkologie. ,vol. 27, pp. 559- 562 ,(2004) , 10.1159/000081338

Julieann Sludden, Sarah C. Hardy, Mark R. VandenBranden, Steven A. Wrighton, Howard L. McLeod, Liver Dihydropyrimidine Dehydrogenase Activity in Human, Cynomolgus Monkey, Rhesus Monkey, Dog, Rat and Mouse Pharmacology. ,vol. 56, pp. 276- 280 ,(1998) , 10.1159/000028209

André B.P. Van Kuilenburg, Rutger Meinsma, Lida Zoetekouw, Albert H. Van Gennip, Increased risk of grade IV neutropenia after administration of 5‐fluorouracil due to a dihydropyrimidine dehydrogenase deficiency: High prevalence of the IVS14+1g>a mutation International Journal of Cancer. ,vol. 101, pp. 253- 258 ,(2002) , 10.1002/IJC.10599

R. MEINSMA, P. FERNANDEZ-SALGUERO, A.B.P. VAN KUILENBURG, A.H. VAN GENNIP, F.J. GONZALEZ, Human Polymorphism in Drug Metabolism: Mutation in the Dihydropyrimidine Dehydrogenase Gene Results in Exon Skipping and Thymine Uracilurea DNA and Cell Biology. ,vol. 14, pp. 1- 6 ,(1995) , 10.1089/DNA.1995.14.1

E. S.R. Collie-Duguid, M. C. Etienne, G. Milano, H. L. McLeod, Known variant DPYD alleles do not explain DPD deficiency in cancer patients. Pharmacogenetics. ,vol. 10, pp. 217- 223 ,(2000) , 10.1097/00008571-200004000-00002